Tech Company Financing Transactions
Calistoga Pharmaceuticals Funding Round
On 12/31/2009, Calistoga Pharmaceuticals received funding from Three Arch Partners.
Transaction Overview
Company Name
Announced On
12/31/2009
Transaction Type
Venture Equity
Amount
Unknown
Round
Undisclosed
Investors
Three Arch Partners (Richard Lin)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
2101 - 4th Ave. 1960
Seattle, WA 98121
USA
Seattle, WA 98121
USA
Phone
Website
Email Address
Overview
Calistoga Pharmaceuticals, is developing a drug candidate acquired from Icos that has potential to treat various forms of cancer.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Carol Gallagher
Chief Financial Officer
Andrew Guggenhime
Chief Medical Officer
Albert Yu
VP - R & D
Langdon Miller
Browse more venture capital transactions:
Prev: 12/31/2009: Diroda Therapeutics venture capital transaction
Next: 12/31/2009: Cequent Pharmaceuticals venture capital transaction
Share this article
About Database of VC Transactions
We do our best to record every notable VC transaction. VC transactions reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs